Difficulty: Easy
Correct Answer: Microfiltration through a 0.22 μm membrane
Explanation:
Introduction / Context:
Many antibiotics are heat-labile and lose potency when exposed to sterilizing temperatures. Pharmacy compounding and laboratory practice therefore rely on non-thermal sterilization methods.
Given Data / Assumptions:
Concept / Approach:
Microfiltration with sterile 0.22 μm membranes retains bacteria and most fungal cells while allowing small molecules (such as antibiotics) to pass. This yields a sterile filtrate without heat exposure. Heat methods (dry heat, autoclaving) risk drug degradation; desiccation and incineration are inapplicable.
Step-by-Step Solution:
Rule out thermal methods due to heat lability.Select membrane filtration as the validated, non-thermal sterilization for solutions.Choose ‘‘Microfiltration through a 0.22 μm membrane’’.
Verification / Alternative check:
Pharmacopeial standards (aseptic processing) specify sterilizing-grade filters (≤0.22 μm) for parenteral solutions when terminal sterilization is not feasible.
Why Other Options Are Wrong:
Dry heat/autoclaving degrade heat-sensitive drugs; desiccation does not sterilize; incineration destroys the product entirely.
Common Pitfalls:
Using 0.45 μm filters (not sterilizing-grade) or assuming filtration removes viruses/endotoxin; additional controls may be needed for those.
Final Answer:
Microfiltration through a 0.22 μm membrane.
Discussion & Comments